ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
122.102,15
0,75%
S&P 500
5.930,85
1,09%
US Dollar vs BRL
6,086
0,00%
Bitcoin
97.445,40
-0,32%
Brent Oil
72,72
0,00%
As Melhores Corretoras Online
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. IRIDEX Corporation (IRIX)

  7. IRIDEX Corporation (IRIX) Notícias

IRIX

IRIDEX (IRIX)

IRIDEX Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:IRIX
DataHoraFonteTítuloCódigoCompanhia
18/12/202418:05GlobeNewswire Inc.Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma ManagementNASDAQ:IRIXIRIDEX Corporation
19/11/202410:14GlobeNewswire Inc.Iridex Comments on Changing Glaucoma Reimbursement LandscapeNASDAQ:IRIXIRIDEX Corporation
13/11/202419:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRIXIRIDEX Corporation
12/11/202418:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRIXIRIDEX Corporation
12/11/202418:05GlobeNewswire Inc.Iridex Reports Third Quarter 2024 Financial ResultsNASDAQ:IRIXIRIDEX Corporation
08/11/202421:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRIXIRIDEX Corporation
04/11/202418:05GlobeNewswire Inc.Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024NASDAQ:IRIXIRIDEX Corporation
03/10/202417:05GlobeNewswire Inc.Iridex Appoints Patrick Mercer as Chief Executive OfficerNASDAQ:IRIXIRIDEX Corporation
25/09/202417:05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:IRIXIRIDEX Corporation
25/09/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IRIXIRIDEX Corporation
05/09/202417:04Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:IRIXIRIDEX Corporation
08/08/202417:05GlobeNewswire Inc.Iridex Reports Second Quarter 2024 Financial ResultsNASDAQ:IRIXIRIDEX Corporation
05/08/202409:00GlobeNewswire Inc.Iridex Announces Convertible Note FinancingNASDAQ:IRIXIRIDEX Corporation
30/07/202417:05GlobeNewswire Inc.Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024NASDAQ:IRIXIRIDEX Corporation
31/05/202414:07Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:IRIXIRIDEX Corporation
14/05/202417:05GlobeNewswire Inc.Iridex Reports First Quarter 2024 Financial ResultsNASDAQ:IRIXIRIDEX Corporation
08/05/202417:05GlobeNewswire Inc.Iridex to Report First Quarter 2024 Financial Results on May 14, 2024NASDAQ:IRIXIRIDEX Corporation
26/03/202417:05GlobeNewswire Inc.Iridex Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:IRIXIRIDEX Corporation
20/03/202417:05GlobeNewswire Inc.Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024NASDAQ:IRIXIRIDEX Corporation
06/02/202410:00GlobeNewswire Inc.Iridex Corporation Receives European Patent on MicroPulse TechnologyNASDAQ:IRIXIRIDEX Corporation
24/01/202410:00GlobeNewswire Inc.Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS TrustNASDAQ:IRIXIRIDEX Corporation
11/01/202420:45GlobeNewswire Inc.Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & GlaucomaNASDAQ:IRIXIRIDEX Corporation
28/12/202320:00GlobeNewswire Inc.Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted CyclophotocoagulationNASDAQ:IRIXIRIDEX Corporation
27/11/202311:00GlobeNewswire Inc.Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of CyclophotocoagulationNASDAQ:IRIXIRIDEX Corporation
14/11/202318:21GlobeNewswire Inc.Iridex Reports Third Quarter 2023 Financial Results and Business UpdateNASDAQ:IRIXIRIDEX Corporation
13/11/202311:00GlobeNewswire Inc.Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023NASDAQ:IRIXIRIDEX Corporation
26/10/202317:22GlobeNewswire Inc.Iridex to Report Third Quarter Financial Results on November 14, 2023NASDAQ:IRIXIRIDEX Corporation
29/08/202317:05GlobeNewswire Inc.Iridex Announces Strategic Review to Unlock Shareholder ValueNASDAQ:IRIXIRIDEX Corporation
10/08/202317:05GlobeNewswire Inc.Iridex Reports Second Quarter 2023 Financial ResultsNASDAQ:IRIXIRIDEX Corporation
27/07/202317:05GlobeNewswire Inc.Iridex to Report Second Quarter Financial Results on August 10, 2023NASDAQ:IRIXIRIDEX Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:IRIX

Seu Histórico Recente

NASDAQ
CRUS
Cirrus Logic
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados